Date: July 16, 2020 Source 1: Duke-NUS Medical School Source 2: www.sciencedaily.com Summary: The T cells, along with antibodies, are an integral part of the human immune response against viral infections due to their ability to directly target and kill infected cells. A Singapore study has uncovered the presence of virus-specific T cell immunity in […]
NIAID-sponsored Phase 1 trial tested mRNA vaccine Date: July 14, 2020 Source 1: NIH/National Institute of Allergy and Infectious Diseases Source 2: www.sciencedaily.com Summary: An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to
Date: July 13, 2020 Source 1: Michigan Medicine – University of Michigan Source 2: www.sciencedaily.com Summary: Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off ventilator within a month, despite double the risk of additional infection, according to a new study. Critically ill COVID-19 patients
